Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure. - Wikidata - wikimedia - TriplyDB

Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure.

Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure.

http://www.wikidata.org/entity/Q37422663

about

Neonatal pain management: still in search for the Holy Grail Association of Variants of Arginine Vasopressin and Arginine Vasopressin Receptor 1A With Severe Acetaminophen Liver Injury.A systems biology approach utilizing a mouse diversity panel identifies genetic differences influencing isoniazid-induced microvesicular steatosis.PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses.Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen Acetaminophen-induced liver injury in obesity and nonalcoholic fatty liver disease.Pharmacogenomics of acetaminophen in pediatric populations: a moving target.Acetaminophen hepatotoxicity: an updated review.Transcriptome association analysis identifies miR-375 as a major determinant of variable acetaminophen glucuronidation by human liver.The Promise of New Technologies to Reduce, Refine, or Replace Animal Use while Reducing Risks of Drug Induced Liver Injury in Pharmaceutical Development.Are Polymorphisms in Genes Relevant to Drug Disposition Predictors of Susceptibility to Drug-Induced Liver Injury?Race, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American Volunteers.Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature.Editor's Highlight: Candidate Risk Factors and Mechanisms for Tolvaptan-Induced Liver Injury Are Identified Using a Collaborative Cross Approach.Paracetamol metabolism, hepatotoxicity, biomarkers and therapeutic interventions: a perspective

P2860

Q28078751-C99E01EF-0DCC-4D13-A56F-761D693C5256 Q33600448-FCD5C632-6CC1-465A-8027-33A1F769C8D8 Q34208933-D49C7FF6-A819-4DBA-AC6F-3598F00DA9BB Q35842112-C2B12E6A-6C05-426D-92BD-024DEB46D9A0 Q36669589-45808439-A735-45DA-A1BF-6F8CE71E49B9 Q38191681-4CAF08E0-7E88-48DA-A7F8-F133CB317DCF Q38263519-6BF5E744-209B-4668-8132-49F4CBC73302 Q38299336-DA3399AB-356B-4D35-A077-62AD6BB0195E Q38751501-FC642B52-41DB-4028-9222-79DB65A25586 Q38774776-FB645711-8E8E-4489-9C27-24CAC3C7BDD1 Q39061191-92AEFEDA-F115-4EF4-9C46-8591258BEA60 Q46140298-ED1C2A6F-1EB5-44F9-AEF2-93D4D81A5678 Q49214888-CE7B2380-FD8C-47BC-891F-22F49F1ACCC8 Q51172729-BB0F98D9-104F-4F23-81E4-B169E8A5FDA2 Q58045340-F13CD68C-B853-4A5D-A8A9-B6DAE6E47F1D

P2860

Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure.

http://www.wikidata.org/entity/Q37422663

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure.

@en

Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure.

@nl

type

label

Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure.

@en

Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure.

@nl

prefLabel

Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure.

@en

Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure.

@nl

P1433

Q37422663-74BCB8A6-7D51-43F5-99D1-0719349DA321

P1476

Q37422663-D62498E0-E019-433D-89CE-79870735C79B

P2093

Q37422663-3E58B68F-FF97-4E33-934D-4E805B1DF82B

Q37422663-5564081A-6BCF-444B-9763-28F8C7E26B68

Q37422663-7B801741-E038-4A97-AA98-E8D40F9CF20D

Q37422663-9F31F276-E349-4A04-ADC1-F567457F383A

Q37422663-BD96FFF9-BE80-4165-AF8D-61D3BBC9F76E

Q37422663-E353281E-0482-4EF6-87B8-6E3FBF7F1664

Q37422663-FB61D49A-DAD0-4680-9F06-0CA9AA995F6D

P2860

Q37422663-0D4BA2AB-6CE6-4EA2-A302-1C6AC846DBE2

Q37422663-293F3A6F-6CB2-4039-989D-FE53E3C3B060

Q37422663-37EFADBC-C576-4311-ABCB-4595259B1B32

Q37422663-38051466-B210-4557-87A2-CFF732AB6654

Q37422663-3FF0558A-9602-49BB-93A3-83DAEB52809C

Q37422663-40483824-3D1A-4CD2-B36E-B82A50CF8AB9

Q37422663-4C5F0711-63F1-47FE-B9CC-0F2B5DD763C5

Q37422663-50CD5271-16EF-4913-92C5-FE47C10C972A

Q37422663-69FF7781-6D30-4AD1-8743-E7362A41FBDE

Q37422663-847FD68C-FCE5-41C0-B988-8A905708BFBB

P304

Q37422663-37666B9C-BF96-4983-9B0A-77B7CEA1B35F

P31

Q37422663-9E522CEF-9DF6-43C3-8778-CB0F052DBE5F

P356

Q37422663-35541F7E-A1FA-41E1-AB9B-487CA614CEF6

P433

Q37422663-9DCFFAD7-F3CF-420A-86DA-8D1295CB2CA9

P478

Q37422663-7A2934F2-772F-413D-B6E1-9B19C1011831

P577

Q37422663-54DA8CD0-308C-4B09-81ED-539C1E347990

P5875

Q37422663-CCC0203F-2FAF-487D-8259-3B6F2AD7D51A

P698

Q37422663-49D41733-6792-4518-8698-5AC092288A2F

P932

Q37422663-1082AF4F-1BB1-49CE-A553-5A660F19FB97

P356

P1433

Drug Metabolism and Disposition

P1476

Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure.

@en

P2093

Acute Liver Failure Study Group

http://www.w3.org/2001/XMLSchema#string

David J Greenblatt

http://www.w3.org/2001/XMLSchema#string

Inga Peter

http://www.w3.org/2001/XMLSchema#string

Magdalini Vasiadi

http://www.w3.org/2001/XMLSchema#string

Michael H Court

http://www.w3.org/2001/XMLSchema#string

Suwagmani Hazarika

http://www.w3.org/2001/XMLSchema#string

William M Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes

UDP-glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver

Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system.

An integrative genomic analysis identifies Bhmt2 as a diet-dependent genetic factor protecting against acetaminophen-induced liver toxicity.

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.

Glucuronidation of acetaminophen is independent of UGT1A1 promotor genotype.

Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study.

Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial.

Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure

The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C>G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-

P304

28-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/DMD.113.053546

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257533683

http://www.w3.org/2001/XMLSchema#string

P698

24104197

http://www.w3.org/2001/XMLSchema#string

P932

3876784

http://www.w3.org/2001/XMLSchema#string